163 related articles for article (PubMed ID: 24398820)
21. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.
Järbe TU; Gifford RS; Makriyannis A
Eur J Pharmacol; 2010 Dec; 648(1-3):133-8. PubMed ID: 20854804
[TBL] [Abstract][Full Text] [Related]
23. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.
Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G
Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428
[TBL] [Abstract][Full Text] [Related]
24. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
[TBL] [Abstract][Full Text] [Related]
25. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
Wakley AA; Rasmussen EB
Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
[TBL] [Abstract][Full Text] [Related]
26. Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation.
Jewett DC; Hahn TW; Smith TR; Fiksdal BL; Wiebelhaus JM; Dunbar AR; Filtz CR; Novinska NL; Levine AS
Psychopharmacology (Berl); 2009 Apr; 203(2):453-9. PubMed ID: 18854986
[TBL] [Abstract][Full Text] [Related]
27. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
Pério A; Barnouin MC; Poncelet M; Soubrié P
Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors.
Dipatrizio NV; Simansky KJ
Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1409-14. PubMed ID: 18768763
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice.
El-Ghundi M; O'Dowd BF; Erclik M; George SR
Eur J Neurosci; 2003 Feb; 17(4):851-62. PubMed ID: 12603275
[TBL] [Abstract][Full Text] [Related]
30. Naloxone and rimonabant reduce the reinforcing properties of exercise in rats.
Rasmussen EB; Hillman C
Exp Clin Psychopharmacol; 2011 Dec; 19(6):389-400. PubMed ID: 21707193
[TBL] [Abstract][Full Text] [Related]
31. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
32. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
Pavón FJ; Serrano A; Pérez-Valero V; Jagerovic N; Hernández-Folgado L; Bermúdez-Silva FJ; Macías M; Goya P; de Fonseca FR
J Neuroendocrinol; 2008 May; 20 Suppl 1():116-23. PubMed ID: 18426510
[TBL] [Abstract][Full Text] [Related]
33. Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: Exploration of a binge-like eating model.
Presby RE; Rotolo RA; Yang JH; Correa M; Salamone JD
Pharmacol Biochem Behav; 2020 Feb; 189():172851. PubMed ID: 31931017
[TBL] [Abstract][Full Text] [Related]
34. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
[TBL] [Abstract][Full Text] [Related]
35. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
36. The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats.
Schäfer A; Pfrang J; Neumüller J; Fiedler S; Ertl G; Bauersachs J
Br J Pharmacol; 2008 Jul; 154(5):1047-54. PubMed ID: 18469848
[TBL] [Abstract][Full Text] [Related]
37. Role of food type in yohimbine- and pellet-priming-induced reinstatement of food seeking.
Nair SG; Gray SM; Ghitza UE
Physiol Behav; 2006 Jul; 88(4-5):559-66. PubMed ID: 16806322
[TBL] [Abstract][Full Text] [Related]
38. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.
Freedland CS; Whitlow CT; Smith HR; Porrino LJ
Brain Res; 2003 Feb; 962(1-2):169-79. PubMed ID: 12543468
[TBL] [Abstract][Full Text] [Related]
39. Corn oil, but not cocaine, is a more effective reinforcer in obese than in lean Zucker rats.
Townsend EA; Beloate LN; Huskinson SL; Roma PG; Freeman KB
Physiol Behav; 2015 May; 143():136-41. PubMed ID: 25744935
[TBL] [Abstract][Full Text] [Related]
40. Allopregnanolone produces hyperphagia by reducing neophobia without altering food palatability.
Fudge MA; Kavaliers M; Ossenkopp KP
Eur Neuropsychopharmacol; 2006 May; 16(4):272-80. PubMed ID: 16246529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
